GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
19.85
+0.26 (1.30%)
At close: Apr 28, 2026, 4:00 PM EDT
19.93
+0.08 (0.42%)
After-hours: Apr 28, 2026, 6:19 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $1.23 billion as of April 28, 2026. Its market cap has increased by 129.22% in one year.
Market Cap
1.23B
Enterprise Value
948.61M
1-Year Change
129.22%
Ranking
Category
Stock Price
$19.85
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.23B, an increase of 52.32%. That is a compound annual growth rate of 9.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.22B | 54.29% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 1.40B |
| Olema Pharmaceuticals | 1.39B |
| Wave Life Sciences | 1.37B |
| Corvus Pharmaceuticals | 1.35B |
| Jade Biosciences | 1.33B |
| Savara | 1.33B |
| Novavax | 1.31B |
| MapLight Therapeutics | 1.30B |